All Cancer News

ALASSCA Trial Results – 2025 ASCO Gastrointestinal Cancer Symposium.   The ALASCCA trial, recently presented at ASC0 2025, evaluated aspirin after colorectal cancer resection in patients whose tumou ...

Link to the BBC News article Scientific journal reports that ‘Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity’ Findings in the paper published in Nature on 5 ...

This headline, recently seen in the news, reports on a new journal publication which looked at a large number of previous studies. The researchers bought together data from studies of people with canc ...

A pre-planned feasibility analysis (based on run-in data from 2253 participants across all tumour cohorts), suggested that aspirin is well-tolerated after radical therapy, with a low burden of toxicit ...